Ronald Kirk Huntsman - May 25, 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ SEAN McKENDRY as attorney-in-fact for R. Kirk Huntsman
Stock symbol
VVOS
Transactions as of
May 25, 2021
Transactions value $
$21,520
Form type
4
Date filed
5/25/2021, 09:45 PM
Previous filing
Jun 29, 2021
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VVOS Common Stock Purchase $21.5K +4K +266.67% $5.38* 5.5K May 25, 2021 Direct F1
holding VVOS Common Stock 1.75M May 25, 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VVOS Stock Option 333K May 25, 2021 Common Stock 333K $1.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.335 to $5.40.
F2 Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F3 The option provides for vesting in five equal annual installments beginning on January 15, 2017.